Back to Journals » Therapeutics and Clinical Risk Management » Volume 20

ISSN: 1178-203X


Archive: Volume 20, 2024

Factors Associated with Recurrent Emergency Department Visits for Epistaxis in Adults, Cross Sectional Study in Two Tertiary Care Hospitals in Riyadh, Saudi Arabia

Alghofili M, Alwhaibi B, Alassaf AM, Aldhasee OW, Aljerian N, Alsubaie N, Alhussien A, Alsaleh S

Therapeutics and Clinical Risk Management 2024, 20:955-962

Published Date: 28 December 2024

Adoption of Digital Therapeutics in Europe

Fassbender A, Donde S, Silva M, Friganovic A, Stievano A, Costa E, Winders T, van Vugt J

Therapeutics and Clinical Risk Management 2024, 20:939-954

Published Date: 27 December 2024

Risk Factors for Digital Replantation Failure: A Nomogram Prediction Model

Guo T, Ma T, Gao R, Yu K, Bai J

Therapeutics and Clinical Risk Management 2024, 20:929-937

Published Date: 27 December 2024

Clinical and Radiological Factors Associated with Nonoperative Management Failure for Small Bowel Obstruction: A Retrospective Study from a Resource-Limited Setting

Al-wageeh S, Alyhari Q, Ahmed F, Mohammed H, Dahan N, Almohtadi AM, AL-Nuzili Jnr STS, Badheeb M, Naji A

Therapeutics and Clinical Risk Management 2024, 20:893-906

Published Date: 25 December 2024

Predicting Bleeding Related Events in Robotic-Assisted Partial Nephrectomy for Angiomyolipoma: Simplifying Risk Assessment with Tumor Diameter and Depth, A Retrospective Study

Chen MC, Chang YH, Sheng TW, Huang LK, Kan HC, Liu CY, Lin PH, Yu KJ, Chuang CK, Pang ST, Wu CT, Shao IH

Therapeutics and Clinical Risk Management 2024, 20:883-892

Published Date: 21 December 2024

Effect of Levosimendan on Low Cardiac Output Syndrome After Pericardiectomy

Fang L, Zhu P, Yu G, Lv W, Hu J

Therapeutics and Clinical Risk Management 2024, 20:861-869

Published Date: 13 December 2024

The Efficacy and Safety Profile of Balanced Propofol Sedation for Bronchoscopy

Wu X, Zhang L, Zhou Z, Qi L, Liu Y, Du X, Ma L, Ji X

Therapeutics and Clinical Risk Management 2024, 20:849-860

Published Date: 12 December 2024

Atrial Fibrillation Types and Chronic Kidney Disease are Independent Predictors of Atrial Fibrillation Recurrence After Radiofrequency Ablation

Mo P, Fan C, Chen J, Wang Y, Xiao W, Peng Z, Lin XZ, Luo CF, Zhang C

Therapeutics and Clinical Risk Management 2024, 20:817-828

Published Date: 3 December 2024

Is the High-Intensity Focused Electromagnetic Energy an Effective Treatment for Urinary Incontinence in Women?

Tosun H, Akınsal EC, Sönmez G, Baydilli N, Demirci D

Therapeutics and Clinical Risk Management 2024, 20:811-816

Published Date: 30 November 2024

Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe β-Thalassemia Patients

Yang WJ, Shi LD, Liang Y, Liang LM, Zhang H, Wang L, Zhou Q

Therapeutics and Clinical Risk Management 2024, 20:799-809

Published Date: 29 November 2024

Introducing Angle B: A Novel Quantitative Approach for Sagittal Alignment Reduction in Atlanto-Axial Dislocation Surgery

Cui S, Wang X, Li K, Feng H, Liu Z, Jian F, Wang K

Therapeutics and Clinical Risk Management 2024, 20:789-797

Published Date: 26 November 2024

Haemodynamic Changes in Adult Patients Transported in Emergency Medical Helicopters. A Systematic Review

Artero-García A, Gómez-Salgado J, Fernández-Carrasco FJ, Vázquez-Lara JM, García-Iglesias JJ, Mérida-Yáñez B, Muñoz-Vela FJ, Rodríguez-Díaz L

Therapeutics and Clinical Risk Management 2024, 20:775-787

Published Date: 23 November 2024

Leveraging 3D Convolutional Neural Networks for Accurate Recognition and Localization of Ankle Fractures

Wang H, Ying J, Liu J, Yu T, Huang D

Therapeutics and Clinical Risk Management 2024, 20:761-773

Published Date: 20 November 2024

Medications Associated with Geriatric Syndromes and Prescribing Patterns: The Impact of Excessive Polypharmacy in Older Adult Patients

Al-Azayzih A, Al-Qerem W, Al-Azzam S, Alzoubi KH, Jirjees F, Al-Kubaisi K, Kharaba Z, Muflih S, Kanaan RJ, Abandeh AH

Therapeutics and Clinical Risk Management 2024, 20:741-748

Published Date: 29 October 2024

Three Artificial Liver Models of Treatment of Acute-on-Chronic Liver Failure

Xiang Y, Li R, Cai J, Jiang Q

Therapeutics and Clinical Risk Management 2024, 20:731-740

Published Date: 25 October 2024

The Impact of Bispectral Index Monitoring on Outcomes in Spinal Cord Stimulation for Chronic Disorders of Consciousness

Chen X, Qin X, Zhuang Y, Li Z, Liang Z, Zhang H, Yao L, Li X, He J, Guo X

Therapeutics and Clinical Risk Management 2024, 20:677-687

Published Date: 27 September 2024

Frailty Predicts in-Hospital Death in Traumatic Brain Injury Patients: A Retrospective Cohort Study

Liu H, Wu W, Xu M, Ling X, Lu W, Cheng F, Wang J

Therapeutics and Clinical Risk Management 2024, 20:665-675

Published Date: 23 September 2024

Experts’ Opinion in Fabry Disease Management and the Unmet Medical Need: The Saudi Perspective

Alfadhel M, Al Sannaa N, Sunbul R, Al-Khawaja H, Askandarani S, Alanzi T, Elawad M, Fourtounas K

Therapeutics and Clinical Risk Management 2024, 20:641-652

Published Date: 13 September 2024

Drug Therapy Problems Identified by Clinical Pharmacists at a General Surgery Ward of an Academic Referral Hospital in Jordan

Al Fahmawi H, Albsoul-Younes A, Saleh M, Abu-Abeeleh M, Kasabri V

Therapeutics and Clinical Risk Management 2024, 20:619-631

Published Date: 11 September 2024

Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia

Romanová T, Burša F, Sklienka P, Sagan J, Vaňková M, Buršík D, Bílená M, Pulcer M, Burda M, Máca J

Therapeutics and Clinical Risk Management 2024, 20:611-618

Published Date: 10 September 2024

Impact of Isotretinoin on Blood Lipids and Liver Enzymes: A Retrospective Cohort Study in Saudi Arabia

Alrasheed AA, Alsadhan KF, Alfawzan NF, AbuDujain NM, Alnasser AH, Almousa H

Therapeutics and Clinical Risk Management 2024, 20:567-575

Published Date: 4 September 2024

Risk Assessment Tool in Predicting the Therapeutic Outcomes of Antiseizure Medication in Adults with Epilepsy

Rusli RA, Makmor Bakry M, Mohamed Shah N, Loo XL, Hung SKY

Therapeutics and Clinical Risk Management 2024, 20:529-541

Published Date: 26 August 2024

Risk Stratification of Penicillin Allergy Labeled Children: A Cross-Sectional Study from Jordan

Alsulaiman JW, Kheirallah KA, Alrawashdeh A, Saleh T, Obeidat M, Alawneh YJ, Abu Sanad Z, Amayreh W, Alawneh RJ

Therapeutics and Clinical Risk Management 2024, 20:505-514

Published Date: 22 August 2024

Risk Factors and Electromyographic Characteristics of Acquired Weakness in Critically Ill Patients: A Retrospective Study

Li K, Alhaskawi A, Zhou H, Dong Y, Zhao Q, Wang C, Lu H

Therapeutics and Clinical Risk Management 2024, 20:451-463

Published Date: 1 August 2024

Invasive Listeriosis in End-Stage Kidney Disease (ESKD) Patients Receiving Long-Term Dialysis: A 21-Year Case Series

Liu YC, Liau SK, Hung CC, Chen CY, Lu YA, Lin YJ, Tian YC, Chen YC, Tseng FG, Hsu HH

Therapeutics and Clinical Risk Management 2024, 20:437-447

Published Date: 16 July 2024

Effects of Family-Supported Healthcare on Children with Asthma

Shao M, Liu Z, Liu T

Therapeutics and Clinical Risk Management 2024, 20:427-436

Published Date: 15 July 2024

Experiential Learning with Ketamine: A Mixed-Methods Exploratory Study on Prescription and Perception

Ilg AM, Beltran CP, Shih JA, Yankama TT, Hayes MM, Moskowitz AL

Therapeutics and Clinical Risk Management 2024, 20:381-390

Published Date: 21 June 2024

Resilience in Rectal Cancer Treatment: Lessons from the COVID-19 Era in Czech Republic

Ihnát P, Martínek L, Tulinský L, Kala Z, Grolich T, Gurlich R, Šturma J, Klos D, Špička P, Neoral Č, Černý V

Therapeutics and Clinical Risk Management 2024, 20:373-379

Published Date: 17 June 2024

The Effect of Vidian Neurectomy on the Ocular Surface – The Primary Results from a Six-Month Pilot Study

Wan X, Lin T, Luo Y, Hong J, Cheng J, Zhao K

Therapeutics and Clinical Risk Management 2024, 20:335-340

Published Date: 7 June 2024

Effect of Tranexamic Acid on Hidden Blood Loss in Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion: A Retrospective Study

Li Y, Ge M, Tian J, Zhou J, Kang Y, Xia C, Shao H, Wang Y, Huang Y, Zhao T

Therapeutics and Clinical Risk Management 2024, 20:325-334

Published Date: 29 May 2024

The Important Role of Preoperative D-Dimer in Constrictive Pericarditis

Fang L, Zhong F, Yu W, Zhu P, Yu G

Therapeutics and Clinical Risk Management 2024, 20:239-247

Published Date: 6 May 2024

Risk Factors of Chylothorax After Congenital Heart Surgery in Infants: A Single-Centre Retrospective Study

Zhang RG, Liu YM, Yao ZY, Fang JX, Li Y, Zheng ML, Sun X, Wen SS, Wang XM, Zhuang J, Luo DD, He SR

Therapeutics and Clinical Risk Management 2024, 20:161-168

Published Date: 5 March 2024

Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram

Jung YS, Jin BH, Choi JE, Park MS, Kim YW, Kang HW, Cho S, Kim CO

Therapeutics and Clinical Risk Management 2024, 20:151-160

Published Date: 26 February 2024

Effectivity of Virtual Reality to Improve Balance, Motor Function, Activities of Daily Living, and Upper Limb Function in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis

Komariah M, Amirah S, Abdurrahman MF, Handimulya MFS, Platini H, Maulana S, Nugrahani AD, Mulyana AM, Qadous SG, Mediani HS, Mago A

Therapeutics and Clinical Risk Management 2024, 20:95-109

Published Date: 14 February 2024

Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records

Bindra J, Chopra I, Hayes K, Niewoehner J, Panaccio MP, Wan GJ

Therapeutics and Clinical Risk Management 2024, 20:83-94

Published Date: 9 February 2024

Minimally Invasive Treatment of Chyle Leak After Thyroidectomy and Cervical Lymph Node Dissection in Patients with Thyroid Carcinoma: Results of a Study Involving 36 Patients

Cuong NN, Hoan L, Tra My TT, Luu DT, Tuan Linh L, Canh PH, Tinh TQ, Khanh Chi TN, Trung NQ, Hoa TQ

Therapeutics and Clinical Risk Management 2024, 20:75-82

Published Date: 9 February 2024

Treatment Patterns and FLT3 Mutation Testing Among Patients with Acute Myeloid Leukemia in China: A Retrospective Observational Study

Cheng LJ, Gong B, Young CH, Krishnan P, Wang Y, Wei H, Zhou C, Wei S, Li Y, Fang Q, Zhong J, Wu EQ, Mi Y, Wang J

Therapeutics and Clinical Risk Management 2024, 20:59-73

Published Date: 8 February 2024

LASSO-Based Identification of Risk Factors and Development of a Prediction Model for Sepsis Patients

Hong C, Xiong Y, Xia J, Huang W, Xia A, Xu S, Chen Y, Xu Z, Chen H, Zhang Z

Therapeutics and Clinical Risk Management 2024, 20:47-58

Published Date: 7 February 2024

Factors Influencing the Fasting Time in Adult Patients After the Endoscopic Management of Sharp Esophageal Foreign Bodies

Wu DQ, Chen SY, Chen KG, Wang T, Li GY, Huang XS

Therapeutics and Clinical Risk Management 2024, 20:39-45

Published Date: 5 February 2024

The Potential of Autologous Platelet-Rich Plasma Gel for Diabetic Foot Ulcer Care Among Older Adults: A Systematic Review and Meta-Analysis

Platini H, Adammayanti KA, Maulana S, Putri PMK, Layuk WG, Lele JAJMN, Haroen H, Pratiwi SH, Musthofa F, Mago A

Therapeutics and Clinical Risk Management 2024, 20:21-37

Published Date: 25 January 2024

Hard-Candy Consumption Does Not Have an Effect on Volume and pH of Gastric Content in Patients Undergoing Elective Gastrointestinal Endoscopic Procedures: A Randomized Controlled Trial [Corrigendum]

Somnuke P, Kitisin N, Chumklud P, Kunavuttitagool P, Deepinta P, Wadrod A, Prachayakul W, Amornyotin S, Raykateeraroj N

Therapeutics and Clinical Risk Management 2024, 20:19-20

Published Date: 17 January 2024